跳至主要内容
临床试验/NCT03371641
NCT03371641招募中不适用

In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions

University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年1月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
PLGF concentrations in placenta

研究概览

简要总结

This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant woman (monofetal or twin pregnancy, whatever the parity)
  • Age> or = to 18 years
  • Person affiliated to a social security system
  • Person who read and understood the information form and signed the consent form
  • Alcohol exposure group Chronic consumption of at least 30 g of alcohol per week or acute consumption of "binge drinking" type during pregnancy (knowing that a unit of 10 g of pure alcohol corresponds to 25 cl of beer 4 ° 5, 10 cl of wine at 12 °, 3 cl of whiskey, 7 cl of Porto ...)
  • Control group No alcohol consumption during pregnancy
  • Child Informed parents and written consent signed by the father and mother for the child's participation in this research (unless one of the parents does not have parental authority)

排除标准

  • Female under 18
  • Pregnant woman with clinical suspicion of pre-eclampsia and / or HELLP syndrome
  • Person deprived of liberty by an administrative or judicial decision or protected major subject (under tutorship or curatorship)
  • Patient participating in another interventional trial or who participated in another interventional trial during pregnancy

研究组 & 干预措施

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: ASQ parental questionnaire (Behavioral)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Development scales (Behavioral)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Scale of Conners (Behavioral)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: SCQ Questionnaire (Behavioral)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Blood sample (mother) (Procedure)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Cord blood sample (Procedure)

Alcoholic exposure group

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Placenta sample (Procedure)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: ASQ parental questionnaire (Behavioral)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Development scales (Behavioral)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Scale of Conners (Behavioral)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: SCQ Questionnaire (Behavioral)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Blood sample (mother) (Procedure)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Cord blood sample (Procedure)

Control

Other

Blood sample (mother) Cord blood sample Placenta sample ASQ parental questionnaire WPPSI - IV and NEPSY development scales Scale of Conners SCQ questionnaire

干预措施: Placenta sample (Procedure)

结局指标

主要结局

PLGF concentrations in placenta

时间窗: Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions

Compare concentrations between 2 groups of mother / child pairs: in utero exposure to alcohol versus control.

PLGF concentrations in the umbilical cord

时间窗: Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions

Compare concentrations between 2 groups of mother / child pairs: in utero exposure to alcohol versus control.

次要结局

  • Follow-up at 2 years in pediatric consultation for evaluation of neuro-development(2 years)
  • Follow-up at 6 years in consultation for assessment of neurodevelopment with(6 years)
  • Assessment of the concentration of PLGF in maternal blood(Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions)
  • Neurological clinical evaluation(The day of birth)
  • Follow-up at 6 years in consultation for assessment of neuropsychological assessment: SCQ Social Communication Questionnaire(6 years)
  • Studies of metabolomic profile on blood sample(Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions)
  • Studies of metabolomic profile on placenta(Through inclusion completion and samples analyses, an average of 4 months after the end of inclusions)
  • Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Wechsler Preschool and Primary Scale of Intelligence: WPPSI IV(6 years)
  • Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Developmental NEuroPSYchological Assessment(6 years)
  • Follow-up at 6 years in consultation for assessment of neuropsychological assessment: Conners' scale(6 years)

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验